<DOC>
	<DOCNO>NCT00231777</DOCNO>
	<brief_summary>A new intravenous medication test prevention nausea vomit occurs surgery . This new medication compare another intravenous medication already available patient indication .</brief_summary>
	<brief_title>A Study Examine Safety Tolerability MK0517 Prevention Post-Operative Nausea Vomiting ( 0517-015 )</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Open abdominal surgery require 24 hour hospital stay General anesthesia Postoperative opioids ASA status IIII Patient exhibit evidence clinically significant respiratory , metabolic , hepatic , renal dysfunction , cardiovascular condition congestive heart failure ( CHF ) Morbid obesity Patient mentally incapacitate significant emotional psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>